LS Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-23,319
Closed -$2.32M 1762
2019
Q3
$2.32M Buy
23,319
+152
+0.7% +$14.4K 0.14% 158
2019
Q2
$2.14M Sell
23,167
-240
-1% -$22.8K 0.13% 162
2019
Q1
$2.21M Buy
23,407
+669
+3% +$58.5K 0.14% 153
2018
Q4
$1.46M Buy
22,738
+3,335
+17% +$246K 0.1% 209
2018
Q3
$1.74M Sell
19,403
-231
-1% -$20.4K 0.1% 205
2018
Q2
$1.56M Sell
19,634
-93
-0.5% -$7.72K 0.09% 231
2018
Q1
$1.76M Sell
19,727
-511
-3% -$49.1K 0.1% 201
2017
Q4
$2.11M Sell
20,238
-3,016
-13% -$340K 0.12% 159
2017
Q3
$3.39M Buy
23,254
+1,832
+9% +$250K 0.2% 104
2017
Q2
$2.78M Buy
21,422
+11,030
+106% +$1.35M 0.17% 127
2017
Q1
$1.29M Buy
10,392
+1,077
+12% +$129K 0.08% 221
2016
Q4
$1.08M Sell
9,315
-111
-1% -$12.4K 0.08% 227
2016
Q3
$985K Sell
9,426
-1,264
-12% -$137K 0.07% 231
2016
Q2
$1.05M Buy
10,690
+152
+1% +$15.7K 0.07% 232
2016
Q1
$1.05M Buy
10,538
+635
+6% +$65.4K 0.08% 228
2015
Q4
$1.19M Sell
9,903
-322
-3% -$37.3K 0.09% 209
2015
Q3
$1.11M Buy
10,225
+91
+0.9% +$11.3K 0.09% 215
2015
Q2
$1.17M Buy
10,134
+309
+3% +$35.3K 0.09% 209
2015
Q1
$1.13M Sell
9,825
-396
-4% -$47.3K 0.09% 218
2014
Q4
$1.14M Buy
10,221
+2,065
+25% +$218K 0.09% 203
2014
Q3
$773K Buy
8,156
+776
+11% +$70K 0.07% 224
2014
Q2
$634K Sell
7,380
-130
-2% -$9.89K 0.05% 248
2014
Q1
$524K Sell
7,510
-386
-5% -$30.6K 0.04% 287
2013
Q4
$667K Buy
7,896
+5,300
+204% +$419K 0.06% 204
2013
Q3
$200K Buy
2,596
+266
+11% +$18.6K 0.02% 238
2013
Q2
$136K Buy
+2,330
New +$140K 0.02% 242

Other funds holding CELG

LS Investment Advisors's CELG Position: Q4 2019 in Review

LS Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,319 shares — an estimated $2.32M sold.

LS Investment Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.39M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • LS Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • LS Investment Advisors sold 23,319 Celgene Corp shares in Q4 2019, an estimated $2.32M.
  • LS Investment Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • LS Investment Advisors's Celgene Corp position peaked at $3.39M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on LS Investment Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.